Chemoinformaics analysis of 2,6-Dimethyldecane
| Molecular Weight | 170.34 | nRot | 7 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 0 |
| Exact Molecular Weight | 170.203 | nRing | 0 |
| Solubility: LogS | -6.141 | nHRing | 0 |
| Solubility: LogP | 6.06 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 37.3766 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.522 |
| Synth | 2.353 |
| Natural Product Likeliness | 0.822 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.301 |
| MDCK | 0.0000131 |
| BBB | 0.495 |
| PPB | 0.976477 |
| VDSS | 2.724 |
| FU | 0.0242055 |
| CYP1A2-inh | 0.814 |
| CYP1A2-sub | 0.332 |
| CYP2c19-inh | 0.543 |
| CYP2c19-sub | 0.82 |
| CYP2c9-inh | 0.556 |
| CYP2c9-sub | 0.931 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.1 |
| CYP3a4-sub | 0.141 |
| CL | 7.216 |
| T12 | 0.131 |
| hERG | 0.033 |
| Ames | 0.005 |
| ROA | 0.033 |
| SkinSen | 0.787 |
| Carcinogencity | 0.053 |
| EI | 0.977 |
| Respiratory | 0.307 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.574319 |